rs182163363
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The ENST00000324631.13(CACNB2):c.354G>A(p.Ala118=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000512 in 1,614,108 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A118A) has been classified as Likely benign.
Frequency
Consequence
ENST00000324631.13 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNB2 | NM_201596.3 | c.354G>A | p.Ala118= | synonymous_variant | 4/14 | ENST00000324631.13 | NP_963890.2 | |
CACNB2 | NM_201590.3 | c.192G>A | p.Ala64= | synonymous_variant | 3/13 | ENST00000377329.10 | NP_963884.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNB2 | ENST00000324631.13 | c.354G>A | p.Ala118= | synonymous_variant | 4/14 | 1 | NM_201596.3 | ENSP00000320025 | ||
CACNB2 | ENST00000377329.10 | c.192G>A | p.Ala64= | synonymous_variant | 3/13 | 1 | NM_201590.3 | ENSP00000366546 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152166Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00107 AC: 270AN: 251372Hom.: 3 AF XY: 0.00148 AC XY: 201AN XY: 135848
GnomAD4 exome AF: 0.000538 AC: 786AN: 1461824Hom.: 14 Cov.: 31 AF XY: 0.000792 AC XY: 576AN XY: 727218
GnomAD4 genome AF: 0.000263 AC: 40AN: 152284Hom.: 2 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74462
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 17, 2018 | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Brugada syndrome 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 25, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at